Scarica l'app Stockscreener
7.89
1.15%
0.09
Pre-mercato:
7.94
0.05
+0.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Ardelyx Inc Borsa (ARDX) Ultime notizie
Is It Too Late To Consider Ardelyx (ARDX) After The Recent Share Price Surge? - simplywall.st
All You Need to Know About Ardelyx (ARDX) Rating Upgrade to Buy - Yahoo Finance
Palisades Investment Partners LLC Cuts Position in Ardelyx, Inc. $ARDX - MarketBeat
AIGH Capital Management LLC Makes New Investment in Ardelyx, Inc. $ARDX - MarketBeat
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Ardelyx Investors Appeal Dismissal of Medicare Program Lawsuit - Bloomberg Law News
Ardelyx responds to Zydus Lifesciences acquisition reports - CNBC TV18
Ardelyx stock hits 52-week high at 8.06 USD By Investing.com - Investing.com India
ZYDUS EYES ARDELYX ACQUISITION DEAL - ICICI Direct
Ardelyx: Assessment Of Acquisition Rumors (NASDAQ:ARDX) - Seeking Alpha
ARDX: Wedbush Raises Price Target to $19, Maintains Outperform R - GuruFocus
Ardelyx (NASDAQ:ARDX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Ardelyx stock hits 52-week high at 8.06 USD - Investing.com
Wedbush Increases Ardelyx (NASDAQ:ARDX) Price Target to $19.00 - MarketBeat
ARDX: Wedbush Raises Price Target to $19, Maintains Outperform Rating | ARDX Stock News - GuruFocus
Lam Research To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
Demystifying Ardelyx: Insights From 7 Analyst Reviews - Benzinga
Ardelyx (ARDX) price target increased by 12.82% to 13.46 - MSN
Strength Seen in Ardelyx (ARDX): Can Its 15.0% Jump Turn into More Strength? - Nasdaq
Ardelyx, Inc. (NASDAQ:ARDX) Stock Catapults 37% Though Its Price And Business Still Lag The Industry - simplywall.st
Zydus Gets World’s First Menkes Disease Drug Approval Amid Ardelyx Acquisition Speculation - Citeline News & Insights
Grapevine: Zydus in talks to acquire US biopharma firm; K Raheja mulls IPO - VCCircle
Wedbush Raises Ardelyx Price Target to $19 Amid Outperform Rating - Intellectia AI
Health Care Stocks Split As Deal Talk Lifts Select Names - Finimize
Zydus Lifesciences eyes $2.5 billion US biopharma buyout of Ardelyx: Report - Moneycontrol
Zydus Lifesciences plans to acquire Ardelyx for USD 2.5B - Medical Buyer
Ardelyx stock soars on report of potential Zydus Life acquisition By Investing.com - Investing.com South Africa
Ardelyx stock soars on report of potential Zydus Life acquisition - Investing.com
Ardelyx (NASDAQ:ARDX) Trading Up 10.2%Here's What Happened - MarketBeat
Ardelyx Shares Soar as Analysts Raise Price Targets - StocksToTrade
Ardelyx Stock Surges Amid Upgraded Ratings and Revenue Projections - timothysykes.com
Zydus Lifesciences eyes acquisition of US firm Ardelyx for $2.5 billion | Company Business News - Mint
Ardelyx (ARDX) Surges on Potential Acquisition by Zydus Lifesciences - GuruFocus
Ardelyx: IBSRELA Momentum Drives Opportunity (NASDAQ:ARDX) - Seeking Alpha
Zydus Life may acquire US-firm Ardelyx; may fund deal via QIP - India Infoline
Zydus Life to Acquire Ardelyx, Raise Funds via QIP; Shares Flat - Equitypandit
Zydus Lifesciences in talks to acquire US biopharma firm Ardelyx, may raise ₹5,000 crore via QIP - scanx.trade
Zydus Life may acquire US-firm Ardelyx, may raise funds via QIP to part-fund deal: Exclusive - CNBC TV18
Ardelyx stock rises premarket as Piper sees over 100% upside — says constipation drug 'stole the show' with 2026 guidance - MSN
Lobbying Update: $580,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
Ardelyx says 2025 total product revenue was about $378M - MSN
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Exit Recap: Can Ardelyx Inc continue delivering strong returns2025 Market Sentiment & Real-Time Volume Surge Alerts - baoquankhu1.vn
Insider Buy: Can Ardelyx Inc stock outperform in 2025 bull market2025 Biggest Moves & Consistent Income Trade Ideas - Bộ Nội Vụ
Ardelyx (ARDX) Price Target Increased by 12.82% to 13.46 - Nasdaq
Lobbying Update: $30,000 of ARDELYX INC. lobbying was just disclosed | ARDX Stock News - Quiver Quantitative
Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? - Asianet Newsable
Ardelyx (NASDAQ:ARDX) Stock Price Down 6.8% on Insider Selling - MarketBeat
Are Medical Stocks Lagging Ardelyx (ARDX) This Year? - Yahoo Finance
Ardelyx Inc: Citigroup raises target price to $14 from $11 - marketscreener.com
Ardelyx chief patient officer Williams sells $348,900 in stock By Investing.com - Investing.com Australia
Top Ardelyx Executive Executes Significant Stock Sale That Investors Can’t Ignore - TipRanks
Ardelyx chief patient officer Williams sells $348,900 in stock - Investing.com India
Insider Selling: Ardelyx (NASDAQ:ARDX) Insider Sells 50,000 Shares of Stock - MarketBeat
Ardelyx’s Stock Ascends Following Strategic Upgrades and Promising Revenue Projections - StocksToTrade
Why Ardelyx (ARDX) Is Up 20.1% After Lawsuit Dismissal And Patent Extension For Tenapanor - simplywall.st
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):